Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance

Go back to Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance
(NASDAQ: COLL) Delayed: 34.62 +1.17 (3.50%)
Previous Close $33.45    52 Week High $30.58 
Open $33.92    52 Week Low $8.24 
Day High $34.87    P/E N/A 
Day Low $33.79    EPS $0.00 
Volume 317,955